Molecular therapeutics in breast cancer
11 – 20 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
- 2017
-
Mark
Strategies to design clinical studies to identify predictive biomarkers in cancer research
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule
(
- Contribution to journal › Article
-
Mark
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells
(
- Contribution to journal › Article
-
Mark
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium
(
- Contribution to journal › Article
-
Mark
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
(
- Contribution to journal › Article
-
Mark
A novel model of dormancy for bone metastatic breast cancer cells
(
- Contribution to journal › Article